H

Healwell Al Inc
TSX:AIDX

Watchlist Manager
Healwell Al Inc
TSX:AIDX
Watchlist
Price: 0.92 CAD Market Closed
Market Cap: 258.4m CAD

Healwell Al Inc
Investor Relations

Healwell Al Inc is a CA-based company operating in Health Care Providers & Services industry. The company is headquartered in Toronto, Ontario. The company went IPO on 2007-04-25. HEALWELL AI Inc., formerly MCI Onehealth Technologies Inc., is a healthcare technology company focused on artificial intelligence (AI) and data science for preventative care. The firm is engaged in developing and acquiring technology and clinical sciences capabilities. Its clinical information sources consist of clinician and electronic medical records (EMR) access; clinical research and rials; lab and diagnostic info, and semi-structured data. The company offers a range of clinical insights with life sciences companies, precision medicine companies, pharmaceutical companies, and medical device companies.

Show more
Loading
AIDX
S&P TSX Composite Index (Canada)
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q3 2025
Call Date
Nov 7, 2025
AI Summary
Q3 2025

Revenue Surge: HEALWELL reported Q3 2025 revenue of $30.4 million, up 354% year-over-year, mainly due to the Orion Health acquisition and strong organic and inorganic growth.

Profitability Milestone: The company achieved positive adjusted EBITDA of $0.7 million, marking its second consecutive quarter of profitability.

Business Simplification: HEALWELL completed a major business simplification, transforming into a pure-play AI and software company after divesting non-core assets.

AI Expansion: Integration of the DARWEN AI platform into Amadeus software and full ownership of Pentavere expanded HEALWELL's AI capabilities and commercialization efforts.

Strong Cash Position: Ended Q3 with $15.6 million in cash, up from $9.4 million at the end of Q4 2024, supporting growth initiatives.

Global Growth: Announced a joint venture with WELL Health and a partnership with Lean Business Services to expand into the Middle East, with ongoing commercial activity in North America and among top global pharmaceutical companies.

Focus on Commercial Validation: Management emphasized disciplined investment, operating margin improvement, and plans to demonstrate commercial AI validation in health care systems outside life sciences in 2026.

Key Financials
Revenue
$30.4 million
Gross Profit
$16.5 million
Gross Margin
54%
Adjusted EBITDA
$0.7 million
Net Loss from Continuing Operations
$16 million
Cash
$15.6 million
AI and Data Science Segment Revenue
$2 million
Healthcare Software Segment Revenue
$28.4 million
Earnings Call Recording
Other Earnings Calls

Management

Dr. Alexander Julian Dobranowski
Founder, CEO, MD & Director
No Bio Available
Ms. Madeline D. Walker
President of MCI Medical
No Bio Available
Mr. Donald Watts
President of Khure Health
No Bio Available
Mr. Anthony Lam
Chief Financial Officer
No Bio Available
Adam Hutton
Co-Chief Operating Officer
No Bio Available
Nolan Reeds
Vice President of Marketing & Communications
No Bio Available
Mr. Blake Corbet
Senior Vice President of Corporate Development
No Bio Available
Mr. Mark Findlay
Senior Vice President of Sales & Marketing for Canada
No Bio Available

Contacts

Address
ONTARIO
TORONTO
4881 Yonge Street, Suite 300
Contacts